Thursday, Edwards Lifesciences Corp. (EW) reported fourth-quarter net income of $47.6 million or $0.80 per share, compared to net income of $38.1 million or $0.66 per share in the same quarter last year.
Excluding special items, net income was $49.8 million or $0.84 per share, compared to net income of $45.2 million or $0.78 per share in the year ago quarter.
On average, 25 analysts polled by Thomson Reuters expected the company to earn $0.85 per share for the quarter. Analysts' estimates typically exclude special items.
Net sales for the quarter increased 11.9% to $346.7 million from $309.7 million in the comparable quarter last year. Analysts expected the company to report revenue of $342.95 million for the quarter.
Looking ahead to the first quarter, the company expects earnings in the range of $0.77 - $0.81 per share. Analysts currently anticipate the company to earn $0.82 per share for the quarter.
For the full year 2010, the company reaffirmed its prior guidance and expects total sales, excluding special items, in the range of $1.43 billion - $1.50 billion with earnings in the range of $3.50 - $3.60 per share. Analysts currently anticipate the company to earn $3.56 per share on revenue of $1.47 billion for the year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.